Please assess the completion status of the following clinical trial:

Trial Title: The Effects of DHA on Periodontitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age \>40 years~* \>20 natural teeth (excluding third molars)~* no orthodontic appliances~* periodontitis defined as \>4 teeth with pocket probing depths \>5 mm~Exclusion Criteria:~* pregnancy~* diabetes~* severe chronic diseases~* gastrointestinal bleeding~* uncontrolled chronic diseases~* autoimmune disorders~* conditions requiring antibiotic prophylaxis~* warfarin~* clopidogrel~* antimicrobial therapy within 30 days~* chronic use of non-steroidal anti-inflammatory drugs (other than aspirin)~* omega-3 fatty acid use within 6 months~* loose teeth~* painful teeth~* periodontal abscess~* pocket depths \>10 mm in \>1 tooth~* periodontal therapy within the past two years~* allergy to aspirin~* allergy to fish oil~* allergy to corn oil~* allergy to soybean oil

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Aspirin & Docosahexaenoic acid (Type: EXPERIMENTAL): Aspirin 81 mg 1 tablet by mouth daily and Docosahexanoic acid (DHA) 500 mg 4 capsules by mouth daily (total daily dose of 2 grams DHA) for 3 months
- Aspirin & Placebo (Type: ACTIVE_COMPARATOR): Aspirin 81 mg by mouth daily and placebo (50% corn oil/50% soybean oil) 4 capsules by mouth daily for 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).